Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 1 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroma, Acoustic 1 Neurofibromatosis 2 1 Meningioma 1 Ependymoma 1

Interventions

Magnetic Resonance Spectroscopy 283 Specimen Handling 278 pembrolizumab 255 Cyclophosphamide 234 Radiotherapy 229 Nivolumab 183 Cisplatin 174 Biopsy 165 Carboplatin 155 Radiosurgery 142 fludarabine 130 Blood Specimen Collection 130 Gemcitabine 120 Surveys and Questionnaires 117 Paclitaxel 115 venetoclax 112 Standard of Care 112 Dexamethasone 105 Bevacizumab 96 Radiation 95 Rituximab 91 Oxaliplatin 89 Cytarabine 88 Capecitabine 86 Drug Therapy 85 Ipilimumab 83 Doxorubicin 81 durvalumab 80 fludarabine phosphate 73 Fluorouracil 72

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × brigatinib × 90 days × Clear all

NCT04374305 2026-05-06

INTUITT-NF2

Massachusetts General Hospital

Phase 2 Recruiting

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡